MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the ...

New research on Hologic's AI-driven breast cancer detection technologies, including a study focused on invasive lobular cancer, was presented at the Society of Breast Imaging (SBI) Symposium over the ...

Bayer and Hologic have teamed up with the goal of offering clearer breast cancer scans as a package deal—combining the former’s imaging contrast agents with the latter’s mammography hardware. The two ...

Hologic has put forward two studies of its artificial intelligence programs for mammography, showing that an AI tool could maintain high breast cancer detection rates while also simplifying ...

MARLBOROUGH, Mass., June 16, 2026--(BUSINESS WIRE)--Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* ...

General Electric Co. won approval from the Food and Drug Administration to offer its 3-D breast-imaging technology in the U.S., the company said, adding substantial new competition to the fast-growing ...

Breast cancer continues to be a significant global health challenge and the leading cause of cancer-related deaths among women. Artificial Intelligence is playing an increasingly vital role in ...

Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology ...